Maternal and fetal outcome in Swedish women with erythropoietic protoporphyria. - Wikidata - wikimedia - TriplyDB

Maternal and fetal outcome in Swedish women with erythropoietic protoporphyria.

Maternal and fetal outcome in Swedish women with erythropoietic protoporphyria.

http://www.wikidata.org/entity/Q34348847

about

The 6-year follow-up of a Japanese patient with silent erythropoietic protoporphyria Patients with erythropoietic protoporphyria have reduced erythrocyte protoporphyrin IX from early in pregnancy.

P2860

Q33568021-8CAF0C92-6A4B-48EE-B9F3-E89AA524614E Q48164311-4F7D7138-01DF-4EC3-8A8D-CBD9CE9D6B66

P2860

Maternal and fetal outcome in Swedish women with erythropoietic protoporphyria.

http://www.wikidata.org/entity/Q34348847

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Maternal and fetal outcome in Swedish women with erythropoietic protoporphyria.

@ast

Maternal and fetal outcome in Swedish women with erythropoietic protoporphyria.

@en

Maternal and fetal outcome in Swedish women with erythropoietic protoporphyria.

@nl

type

label

Maternal and fetal outcome in Swedish women with erythropoietic protoporphyria.

@ast

Maternal and fetal outcome in Swedish women with erythropoietic protoporphyria.

@en

Maternal and fetal outcome in Swedish women with erythropoietic protoporphyria.

@nl

prefLabel

Maternal and fetal outcome in Swedish women with erythropoietic protoporphyria.

@ast

Maternal and fetal outcome in Swedish women with erythropoietic protoporphyria.

@en

Maternal and fetal outcome in Swedish women with erythropoietic protoporphyria.

@nl

P1433

Q34348847-6DBAEB4B-5A83-4826-8A56-0FFA76E1CFDD

P1476

Q34348847-B077ABAD-F5CB-489E-99E8-73C49BA40A72

P2093

Q34348847-538C60C8-47BF-4EF4-836A-2809FED2CE33

Q34348847-609B6C4F-3AED-4C61-ABC1-2F78FA28B806

Q34348847-CE669869-5DE1-4EB4-AF5A-A0EFBAE90D82

P2860

Q34348847-050D767D-BB01-4788-BD84-0EF7054D6FEC

Q34348847-0EFFE60A-EC82-46C7-B184-03A34D4D8AE1

Q34348847-14F65E87-9FAD-4541-BA67-7671F5A4DF61

Q34348847-38D583E7-FF1A-4681-8271-148BD7E40BF1

Q34348847-3EA854A8-F978-43D7-9394-96AEC3FDF426

Q34348847-4A0D43BA-9670-4BDC-918F-841A9E7696F7

Q34348847-5CE0F65C-593B-4BC1-ACE6-8AECA8FA2E5C

Q34348847-5D9EBB73-A9B5-4006-902A-7FE90EB3DB66

Q34348847-6F717B57-0D88-4CFC-B3A9-B3EE48509161

Q34348847-A750F0E3-D69C-46CD-983F-5749C02387FE

P304

Q34348847-5A16BAC5-9897-4504-BCC0-47B7FAB6CF32

P31

Q34348847-1D1E2ACF-DBFC-423D-B7B5-57FD3B62A435

P356

Q34348847-7C1FD81C-B6E0-44AC-96BD-5CF865E0892D

P407

Q34348847-00412391-0C19-43DB-A9DE-A4766F45B3FC

P433

Q34348847-EAC23291-729C-4E13-8300-1C6A4109D9A3

P478

Q34348847-DBDCEF2E-D9F1-46B9-8F7F-93F55098B779

P577

Q34348847-AEB8F150-E990-4746-A6AE-8164F3B0F870

P5875

Q34348847-A666E671-7EA0-4293-A3E6-902203ED5742

P698

Q34348847-BCCF4002-5B12-434C-994D-893B89A86170

P356

P1433

British Journal of Dermatology

P1476

Maternal and fetal outcome in Swedish women with erythropoietic protoporphyria.

@en

P2093

B Fischler

http://www.w3.org/2001/XMLSchema#string

H-U Marschall

http://www.w3.org/2001/XMLSchema#string

S Wahlin

http://www.w3.org/2001/XMLSchema#string

P2860

C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload

The photodynamic and non-photodynamic actions of porphyrins.

Continuous growth reference from 24th week of gestation to 24 months by gender.

Erythropoietic protoporphyria in Sweden: demographic, clinical, biochemical and genetic characteristics.

Afamelanotide, an agonistic analog of α-melanocyte-stimulating hormone, in dermal phototoxicity of erythropoietic protoporphyria.

Excess risk of adverse pregnancy outcomes in women with porphyria: a population-based cohort study.

Sn-protoporphyrin inhibition of fetal and neonatal brain heme oxygenase. Transplacental passage of the metalloporphyrin and prenatal suppression of hyperbilirubinemia in the newborn animal.

Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life.

Genetic aspects of erythropoietic protoporphyria.

Human protoporphyria: reduced cutaneous photosensitivity and lower erythrocyte porphyrin levels during pregnancy.

P304

1311-1315

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJD.12242

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

168

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237058597

http://www.w3.org/2001/XMLSchema#string

P698

23738640

http://www.w3.org/2001/XMLSchema#string